Withington, United Kingdom

Mamta Shah

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: The University of Manchester, Renovo Limited. Active years: 1997-2001.

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 131(Granted Patents)


Location History:

  • Manchester, GB (1999)
  • Withington, GB (1997 - 2001)

Company Filing History:


Years Active: 1997-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Mamta Shah: Innovator in Wound Healing and Fibrotic Disorder Treatments

Introduction

Mamta Shah is a distinguished inventor based in Withington, GB. She has made significant contributions to the field of medical treatments, particularly in wound healing and fibrotic disorders. With a total of 3 patents to her name, her work has the potential to impact many lives.

Latest Patents

One of Mamta Shah's latest patents focuses on wound healing and the treatment of fibrotic disorders. This innovative healing composition contains at least one non-fibrotic growth factor combined with a pharmaceutically acceptable carrier. The patent also discloses a method for preparing the composition and a method for treating a host suffering from a wound or fibrotic condition, disease, or disorder using this composition.

Career Highlights

Throughout her career, Mamta has worked with notable institutions, including The University of Manchester and Renovo Limited. Her experience in these organizations has allowed her to develop her expertise in medical innovations.

Collaborations

Mamta has collaborated with several professionals in her field, including Mark William Ferguson and Mark William James Ferguson. These collaborations have further enriched her research and development efforts.

Conclusion

Mamta Shah's contributions to wound healing and fibrotic disorder treatments exemplify her dedication to medical innovation. Her patents and collaborations highlight her role as a leading inventor in her field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…